What is the current Non-Opioid Pain Relief Device market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Non-Opioid Pain Relief Device market?

Increasing demand for alternative pain management solutions drives the market.

What are the major challenges faced by the market?

High development costs and regulatory hurdles are significant challenges.

Which regions are leading the Non-Opioid Pain Relief Device market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the Non-Opioid Pain Relief Device market?

Key players include Medtronic, Boston Scientific, and Abbott Laboratories.

What future opportunities can be expected in the market?

Emerging technologies and growing demand in Asia-Pacific offer future opportunities.

How will technology impact the Non-Opioid Pain Relief Device market?

Advances in technology will improve device efficacy and patient outcomes.

What is the current regulatory landscape for the market?

Stringent regulations and safety standards govern the market.

What is the future outlook for the Non-Opioid Pain Relief Device market?

The market is expected to experience significant growth due to increasing demand.

How Big Is the Non-Opioid Pain Relief Device Market? Size, Share & Forecast 2033

Non-Opioid Pain Relief Device by Application (Hospitals, Pain Management Centers, Homecare), by Types (Implantable Device, Non-Implantable Device, Radiofrequency Ablation, Other Emerging Technologies), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-Opioid Pain Relief Device Market Overview

The Non-Opioid Pain Relief Device market refers to the industry that provides alternative solutions for pain management, excluding opioid-based treatments. As the Non-Opioid Pain Relief Device market size is expected to witness significant growth, the growth outlook and market forecast are crucial for industry players. The market forecast indicates a promising future, with the industry expansion driven by increasing demand for effective pain management solutions. The scope of this market encompasses various pain relief devices, including transcutaneous electrical nerve stimulation (TENS) devices, neuromodulation devices, and physical therapy devices. According to recent research, the current Non-Opioid Pain Relief Device market size is approximately $4.5 billion.

Loading chart…

The growth forecast for the Non-Opioid Pain Relief Device market is expected to be driven by a Compound Annual Growth Rate (CAGR) of 7.5%, with macro drivers such as the increasing prevalence of chronic pain, growing awareness about the risks of opioid-based treatments, and advancements in technology. Key forces shaping the industry include technology shifts towards more sophisticated and minimally invasive devices, regulations supporting the development of non-opioid pain relief solutions, and consumer behavior favoring alternative pain management options. The largest region in the Non-Opioid Pain Relief Device market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and a growing patient population.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	20.45 million
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Bayer AG; Bioelectronics Corporation; Boston Scientific Corporation; Medtronic plc; Koninklijke Philips N.V.; NeuroMetrix Inc.; Nuvectra Corporation; Omron Corporation; Stryker Corporation; SPR Therapeutics, LLC; Stimwave LLC; Thermotek Inc.; Zynex Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-Opioid Pain Relief Device market is poised for significant growth, driven by increasing demand for alternative pain management solutions. This section provides an overview of the market dynamics shaping the Non-Opioid Pain Relief Device market size and growth forecast.

Growth Drivers2 items

Rising awareness about the risks associated with opioid-based pain relief medications is driving the adoption of Non-Opioid Pain Relief Devices, contributing to the growth of the Non-Opioid Pain Relief Device market

Advances in technology, such as the development of transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS) devices, are expanding the range of Non-Opioid Pain Relief Device options available to patients and healthcare providers

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players into the Non-Opioid Pain Relief Device market, potentially constraining market growth

Reimbursement challenges and varying insurance coverage policies may hinder the widespread adoption of Non-Opioid Pain Relief Devices, affecting the overall Non-Opioid Pain Relief Device market size

Opportunities2 items

The growing geriatric population and increasing prevalence of chronic pain conditions are creating new opportunities for Non-Opioid Pain Relief Device manufacturers to develop targeted solutions, driving growth in the Non-Opioid Pain Relief Device market

Partnerships and collaborations between Non-Opioid Pain Relief Device manufacturers, healthcare providers, and payers can help improve patient access to these devices, supporting the growth forecast for the Non-Opioid Pain Relief Device market

Challenges2 items

Non-Opioid Pain Relief Device manufacturers must navigate complex and evolving regulatory landscapes, ensuring compliance with changing standards and guidelines

Effective education and training programs are necessary to address the knowledge gap among healthcare providers regarding the use and benefits of Non-Opioid Pain Relief Devices, supporting the long-term growth of the Non-Opioid Pain Relief Device market

Market Segmentation

Loading chart…

The Non-Opioid Pain Relief Device market can be segmented based on Application, which includes various subtypes such as neuropathic pain, musculoskeletal pain, and cancer pain. This segmentation contributes to the overall market size by providing insights into the specific needs of different patient groups. For instance, devices used to treat neuropathic pain may differ from those used for musculoskeletal pain, and understanding these differences is crucial for market players to develop targeted products. The Non-Opioid Pain Relief Device segmentation by application helps companies identify areas of growth and opportunities for innovation.

Another key segmentation category in the Non-Opioid Pain Relief Device market is Types, which encompasses subtypes such as transcutaneous electrical nerve stimulation (TENS) devices, spinal cord stimulation (SCS) devices, and peripheral nerve stimulation (PNS) devices. This segmentation is essential for understanding the market taxonomy and competitive landscape, as different types of devices have varying levels of adoption and market share. By analyzing the types of devices, companies can identify trends and patterns in the market, such as the growing demand for non-invasive devices, and develop strategies to stay ahead of the competition. The market taxonomy of Non-Opioid Pain Relief Device types helps researchers and industry players understand the complex dynamics of the market.

Non-Opioid Pain Relief Device Segmentation Breakdown9 items

Application

Hospitals

Pain Management Centers

Homecare

Types

Implantable Device

Non-Implantable Device

Radiofrequency Ablation

Other Emerging Technologies

Regional Insights

Loading chart…

The Non-Opioid Pain Relief Device market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of non-opioid pain relief devices, favorable government policies, and rising investments in healthcare infrastructure.

Key drivers for North America include high adoption rates, favorable reimbursement policies, and a mature ecosystem. In Europe, key drivers include increasing awareness about non-opioid pain relief devices, stringent regulations against opioid use, and a growing elderly population. The Asia Pacific region is driven by large demographics, increasing healthcare spending, and growing investments in medical devices.

In Latin America, key drivers include rising demand for non-invasive pain relief treatments, improving healthcare infrastructure, and government initiatives to reduce opioid use. The Middle East & Africa region is driven by growing investments in healthcare, increasing adoption of advanced medical technologies, and a rising awareness about non-opioid pain relief devices. These regional forecast trends are expected to shape the Non-Opioid Pain Relief Device market growth in the coming years.

Competitive Landscape

The Non-Opioid Pain Relief Device market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Non-Opioid Pain Relief Device competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are focusing on strategic initiatives to stay competitive, as outlined below:

Abbott Laboratories: regional expansion

Bayer AG: innovation pipeline

Boston Scientific Corporation: premium pricing

Medtronic plc: vertical integration

Koninklijke Philips N.V.: local manufacturing

Bioelectronics Corporation: OEM tie-ups

Key Non-Opioid Pain Relief Device Companies14 items

Abbott Laboratories

Bayer AG

Bioelectronics Corporation

Boston Scientific Corporation

Medtronic plc

Koninklijke Philips N.V.

NeuroMetrix Inc.

Nuvectra Corporation

Omron Corporation

Stryker Corporation

SPR Therapeutics, LLC

Stimwave LLC

Thermotek Inc.

Zynex Medical

Market Ecosystem

The Non-Opioid Pain Relief Device ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem is characterized by a sequence of value-creating activities, from research and development to manufacturing, distribution, and finally, patient care. The ecosystem's boundaries are defined by the interactions among these stakeholders, influencing how value is created and captured.

Raw material suppliers — providing device components

OEMs / manufacturers — designing and producing devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating devices into healthcare systems

Distributors / channel partners — delivering devices to healthcare providers

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — healthcare providers and patients using devices

In the Non-Opioid Pain Relief Device ecosystem, control points are primarily held by regulators and healthcare providers, who influence adoption through standards, approvals, and prescribing practices. Dependency risks arise from input constraints, such as component availability, and standards compliance. Switching costs and partnerships between stakeholders can also impact the ecosystem's dynamics. Furthermore, a thorough value chain analysis is necessary to understand these complexities and how they vary by region, given differences in healthcare systems and regulatory environments.

Recent Industry Insights

The Non-Opioid Pain Relief Device industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding distribution networks. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and accelerate innovation. Furthermore, several product and technology launches have been observed, emphasizing the use of advanced technologies such as transcutaneous electrical nerve stimulation and photobiomodulation to cater to the growing demand for non-invasive pain management solutions.

Additionally, regulatory changes have supported the growth of the Non-Opioid Pain Relief Device market, with governments implementing policies to curb opioid misuse and promote alternative pain relief methods. A shift in consumer trends towards more natural and sustainable solutions has also driven the adoption of non-opioid pain relief devices. Funding rounds and expansions have enabled companies to invest in research and development, leading to the introduction of more effective and user-friendly products that align with the evolving needs of patients and healthcare providers.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-Opioid Pain Relief Device market outlook. The market exhibits high attractiveness due to the growing need for alternatives to opioid-based pain management solutions. The competitive intensity is moderate, with key players focusing on innovative technologies to gain market share. The long-term outlook is positive, driven by increasing demand for non-invasive and safe pain relief solutions.

The innovation landscape is dynamic, with advancements in transcutaneous electrical nerve stimulation and other technologies. The demand-supply balance is favorable, with manufacturers investing in capacity expansion to meet growing demand. However, key risk factors include regulatory challenges and intense competition. Overall, the Non-Opioid Pain Relief Device market outlook is promising, with opportunities for growth and innovation.

12 items

1. Executive Summary

2. Non-Opioid Pain Relief Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Opioid Pain Relief Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-Opioid Pain Relief Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-Opioid Pain Relief Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-Opioid Pain Relief Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Non-Opioid Pain Relief Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-Opioid Pain Relief Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-Opioid Pain Relief Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-Opioid Pain Relief Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Non-Opioid Pain Relief Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-Opioid Pain Relief Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Opioid Pain Relief Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Opioid Pain Relief Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-Opioid Pain Relief Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Non-Opioid Pain Relief Device Market Competition by Key Manufacturers

9.1. Global Non-Opioid Pain Relief Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-Opioid Pain Relief Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott Laboratories

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bayer AG

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bioelectronics Corporation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Boston Scientific Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Medtronic plc

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Koninklijke Philips N.V.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. NeuroMetrix Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Nuvectra Corporation

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Omron Corporation

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Stryker Corporation

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. SPR Therapeutics, LLC

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Stimwave LLC

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Thermotek Inc.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Zynex Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Opioid Pain Relief Device Market

Figure 4: Global Non-Opioid Pain Relief Device Market: Drivers

Figure 5: Global Non-Opioid Pain Relief Device Market: Challenges

Figure 6: Global Non-Opioid Pain Relief Device Market: Trends

Figure 7: Global Non-Opioid Pain Relief Device Market: Opportunity

Figure 8: Global Non-Opioid Pain Relief Device Market: Restraint

Figure 9: Global Non-Opioid Pain Relief Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Non-Opioid Pain Relief Device Market Value (USD Million) By Region

Figure 19: Global Non-Opioid Pain Relief Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Non-Opioid Pain Relief Device Market Value (USD Million) By Region

Figure 27: Global Non-Opioid Pain Relief Device Market Share (%) By: Regions (2032)

Figure 28: Global Non-Opioid Pain Relief Device Market Volume (K) By Region

Figure 29: Global Non-Opioid Pain Relief Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Non-Opioid Pain Relief Device Market Value (USD Million) By Region

Figure 37: Global Non-Opioid Pain Relief Device Market Share (%) By: Regions (2032)

Figure 38: Global Non-Opioid Pain Relief Device Market Volume (K) By Region

Figure 39: Global Non-Opioid Pain Relief Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Opioid Pain Relief Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Opioid Pain Relief Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Opioid Pain Relief Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Non-Opioid Pain Relief Device Market Value (USD Million) By Region

Table 14: Global Non-Opioid Pain Relief Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Non-Opioid Pain Relief Device Market Volume (K) By Region

Table 31: Global Non-Opioid Pain Relief Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Non-Opioid Pain Relief Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-Opioid Pain Relief Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-Opioid Pain Relief Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Laboratories Basic Information And Sales Area

Table 52: Abbott Laboratories. Products Portfolio

Table 53: Bayer AG Basic Information And Sales Area

Table 54: Bayer AG. Products Portfolio

Table 55: Bioelectronics Corporation Basic Information And Sales Area

Table 56: Bioelectronics Corporation. Products Portfolio

Table 57: Boston Scientific Corporation Basic Information And Sales Area

Table 58: Boston Scientific Corporation. Products Portfolio

Table 59: Medtronic plc Basic Information And Sales Area

Table 60: Medtronic plc. Products Portfolio

Table 61: Koninklijke Philips N.V. Basic Information And Sales Area

Table 62: Koninklijke Philips N.V.. Products Portfolio

Table 63: NeuroMetrix Inc. Basic Information And Sales Area

Table 64: NeuroMetrix Inc.. Products Portfolio

Table 65: Nuvectra Corporation Basic Information And Sales Area

Table 66: Nuvectra Corporation. Products Portfolio

Table 67: Omron Corporation Basic Information And Sales Area

Table 68: Omron Corporation. Products Portfolio

Table 69: Stryker Corporation Basic Information And Sales Area

Table 70: Stryker Corporation. Products Portfolio

Table 71: SPR Therapeutics, LLC Basic Information And Sales Area

Table 72: SPR Therapeutics, LLC. Products Portfolio

Table 73: Stimwave LLC Basic Information And Sales Area

Table 74: Stimwave LLC. Products Portfolio

Table 75: Thermotek Inc. Basic Information And Sales Area

Table 76: Thermotek Inc.. Products Portfolio

Table 77: Zynex Medical Basic Information And Sales Area

Table 78: Zynex Medical. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Non-Opioid Pain Relief Device Market Value (USD Million) By Region

Table 88: Global Non-Opioid Pain Relief Device Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Non-Opioid Pain Relief Device Market Volume (K) By Region

Table 105: Global Non-Opioid Pain Relief Device Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-Opioid Pain Relief Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	20.45 million
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Bayer AG; Bioelectronics Corporation; Boston Scientific Corporation; Medtronic plc; Koninklijke Philips N.V.; NeuroMetrix Inc.; Nuvectra Corporation; Omron Corporation; Stryker Corporation; SPR Therapeutics, LLC; Stimwave LLC; Thermotek Inc.; Zynex Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players into the Non-Opioid Pain Relief Device market, potentially constraining market growth

Reimbursement challenges and varying insurance coverage policies may hinder the widespread adoption of Non-Opioid Pain Relief Devices, affecting the overall Non-Opioid Pain Relief Device market size

Opportunities2 items

Challenges2 items

Non-Opioid Pain Relief Device manufacturers must navigate complex and evolving regulatory landscapes, ensuring compliance with changing standards and guidelines

Market Segmentation

Loading chart…

Non-Opioid Pain Relief Device Segmentation Breakdown9 items

Application

Hospitals

Pain Management Centers

Homecare

Types

Implantable Device

Non-Implantable Device

Radiofrequency Ablation

Other Emerging Technologies

Regional Insights

Loading chart…

Competitive Landscape

Abbott Laboratories: regional expansion

Bayer AG: innovation pipeline

Boston Scientific Corporation: premium pricing

Medtronic plc: vertical integration

Koninklijke Philips N.V.: local manufacturing

Bioelectronics Corporation: OEM tie-ups

Key Non-Opioid Pain Relief Device Companies14 items

Abbott Laboratories

Bayer AG

Bioelectronics Corporation

Boston Scientific Corporation

Medtronic plc

Koninklijke Philips N.V.

NeuroMetrix Inc.

Nuvectra Corporation

Omron Corporation

Stryker Corporation

SPR Therapeutics, LLC

Stimwave LLC

Thermotek Inc.

Zynex Medical

Market Ecosystem

Raw material suppliers — providing device components

OEMs / manufacturers — designing and producing devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating devices into healthcare systems

Distributors / channel partners — delivering devices to healthcare providers

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — healthcare providers and patients using devices

Recent Industry Insights

Analyst Overview

Table of Contents